Browsing: preclinical
Sodium-glucose co-transporter 2 (SGLT2) inhibitors, originally developed to treat type 2 diabetes, have significant protective effects on the heart and…
Insilico Medicine (“Insilico”), a clinical-stage genetic artificial intelligence (AI) drug discovery company, successfully delivered its second preclinical compound candidate (PCC)…
Gyros Protein Technologies AB, a pioneer in nanoliter-scale automated immunoassays and a leading provider of peptide synthesizers and reagents, today…
As malaria continues to pose a constant and often fatal threat to billions around the world, new treatments are urgently…